Public Sector Donors Who Increased Funding for HIV Vaccine R&D in 2011 How much did donor funding increase?

Slides:

Advertisements

Similar presentations

From “What If” to “What Now” Perspectives on ARVs and the Future of Treatment and Prevention Mitchell Warren Executive Director, AVAC IAS 2011, Rome.

Advertisements

W.K. Kellogg Foundation: Giving In Communities of Color Fostering An Equitable and Responsive Philanthropic Sector.

HIV Prevention Research & Development Investment in 2013 In a changing global development, economic, and human rights landscape Presented at the International.

COMPANION GRAPHS. Annual Global Plan Research Funding Targets vs Investments $800,000,000 $600,000,000 $400,000,000 $200,000,000 $0 Fundamental.

National Working Group on Microbicides Microbicides advocacy Paramita Kundu & Ananthy Thambinayagam Global Campaign for Microbicides, PATH January 2007.

How well are we doing in preventing HIV and how can we do better?

People receiving antiretroviral therapy, 2005 to June 2014, all countries.

Epidemiology of HIV and Access to Prevention services, Tanzania Joint Biennial HIV National Response Review Stakeholders meeting. November, 2014 Blue Pearl.

WHAT IS GOING ON IN HIV AND AIDS IN 2013 AND BEYOND Prof Alan Whiteside RATN MEETING JOHANNESBURG March 2013.

Results of the Community Foundations mapping project: what we’ve learned and what comes next. Louise Arkles, ACP Discussion facilitated by Alexandra Gartmann.

Rectal Microbicides: The Basics Date, Location Your Name, Organization.

International HIV Assistance from Donor Governments: Commitments & Disbursements, US$ Billions Commitments (Enacted Amounts) Disbursements SOURCES:

© 2014 SAGE Publications, Inc. Chapter 2: Overview of the Nonprofit Sector.

CROWDFUNDING FOR A CAUSE HOW BROAD BASED FUNDING MODELS ARE CHANGING TRADITIONAL PHILANTHROPY GARRETT GOLDBERG IDAHO NONPROFIT CENTER – 10 TH ANNUAL CONFERENCE.

International HIV Assistance from Donor Governments: Commitments & Disbursements, US$ Billions Commitments (Enacted Amounts) Disbursements SOURCES:

HIV/AIDS Treatment and Care Clinical protocols for the WHO European Region 23 November 2007 World AIDS Day Jeffrey V. Lazarus WHO Europe, STI/HIV/AIDS.

Creating an AIDS-Free Generation The beginning of the end of AIDS Center for Strategic & International Studies Washington, DC March 22, 2012 Thomas R.

T reatment A ction G roup Update on Global TB Research By Claire Wingfield Treatment Action Group Advisory Council for the Elimination of Tuberculosis.

2005–2012 NIH Funding for Select Infectious Diseases (in Millions) * Includes ARRA stimulus funds National Institutes of Health (U.S.). Estimates of funding.

Microbicides: Who, what, where, when and how Rebekah Webb Global Campaign for Microbicides © Salam Dahbor,

Sources of Support and What They Mean to the Field Dr. Duff Gillespie June 15 th, 2002 Africa SOTA, Nairobi.

Multipurpose Prevention Technologies What are they & why do we need them? [Presenter name, degree, affiliation] [Event title] [Date]

On the ground advocacy for NPTs: advocacy, education and HIV prevention activities Kadiri Audu IRMA, Nigeria.

OCTOBER 2014 TREATMENT ACTION GROUP MIKE FRICK. Annual Global Plan Research Funding Targets versus 2013 Funding $600,000,000 $800,000,000 $400,000,000.

National Working Group on Microbicides The Basics of Microbicides Amitrajit Saha PATH January 2007.

National Working Group on Microbicides Rectal microbicides: The political landscape Ananthy Thambinayagam, MPH Global Campaign for Microbicides Rectal.

AIDS 2012 Where are we, and where are we going? Mitchell Warren Executive Director, AVAC August 15, 2012.

INVESTING TO END THE AIDS EPIDEMIC: A NEW ERA FOR HIV RESEARCH & DEVELOPMENT HIV VACCINES WORKING GROUP & MICROBICIDES RESOURCE TRACKING E. Donaldson 1,

Multisectoral Programming to Prevent HIV/AIDS among Young People.

Rectal microbicides, where are we? Kim Mulji Naz Foundation International.

The State of Ohio is an Equal Opportunity Employer and Provider of ADA Services. Performance Criteria As of 06/30/2011As of 12/31/2011Percent Change State.

International HIV Assistance from Donor Governments: Disbursements, US$ Billions.

$1 Million $500,000 $100,000 $50,000 $25,000 $10,000 $5,000 $1,000.

Philanthropy Bring it on! HOW CAN PHILANTHROPY BECOME MORE DATA DRIVEN?

Giving: Women and Global Philanthropy. Giving Giving: Women and Global Philanthropy Tewa.

Commodity Promotion Fund AFRICA SOTA June Average Annual Condom Availability in Africa Males 15-59, Average availability measured as.

Tracking the Shortfall in TB Research Funding Javid Syed Treatment Action Group (TAG)

Abt Associates Inc. In collaboration with: I Aga Khan Foundation I Bitrán y Asociados I BRAC University I Broad Branch Associates I Deloitte Consulting,

A pill to prevent HIV? For women??

CAF Grantmaking Services Good Grantmaking Practice Supporting your giving policy.

New Prevention Technologies Workshop Module 2: NPTs in context

The missing chapter of the MDS Anna Forbes, Deputy Director Delhi, 25 February, 2008.

1 06/06 e Global HIV epidemic, 1990 ‒ 2005*HIV epidemic in sub-Saharan Africa, 1985 ‒ 2005* Number of people living with HIV % HIV prevalence, adult (15-49)

International Aid Towards HIV/AIDs in sub-Saharan Africa Ally H. Van Valen.

BRADFORD BRIGGS & NIKE JACKSON. BRADFORD BRIGGS Prevention Toolbox.

1 06/06 e Global HIV epidemic, 1990 ‒ 2005*HIV epidemic in sub-Saharan Africa, 1985 ‒ 2005* Number of people living with HIV % HIV prevalence, adult (15-49)

Microbicides: New Hope for Prevention of HIV and other STIs Your name here

Stacie M. Greby, DVM, MPH American Embassy School January 21, 2010

Blooming Art Debrief Meeting Tuesday, December 6, 2005.

27 years of responding to AIDS

27 years of responding to AIDS

Total Estimated Available Resources for HIV from All Sources

Donor Government Disbursements for HIV,

tracking microbicide funding

FINANCING FOR DATA Partner Report on Support to Statistics

Financial Planning Association of Indiana

FOR HIV PREVENTION RESEARCH & DEVELOPMENT RESOURCE TRACKING

Private sector involvement IPM-Tibotec case study

27 years of responding to AIDS

Evaluating the cost-effectiveness of the test and treat program in Zimbabwe

International HIV Assistance from Donor Governments: Disbursements,

International HIV Assistance from Donor Governments: Disbursements,

Resources available to HIV-related programmes

U.S. Funding for Bilateral HIV, FY 2001 – FY 2019 Request

International HIV Assistance from Donor Governments: Disbursements,

Funders Our thanks to generous support from:. Funders Our thanks to generous support from:

Taking a new look at condoms: Current use and estimates of future need and costs RHSC Meeting, New York April 27, 2006.

US research funding and the importance of public support

PROMOTING PHILANTHROPY in East Sussex

*) Swedish Forest-based Sector Research Agenda 4.0

Presentation transcript:

Public Sector Donors Who Increased Funding for HIV Vaccine R&D in 2011 How much did donor funding increase?

Philanthropic Investment in HIV Vaccine R&D by Foundations and Commercial Philanthropy in 2011 (US$)

Estimated Commercial Engagement in HIV Vaccine R&D by Company in 2011

Annual Investments in Microbicide R&D from 2006–2011 (US$ millions)*

Microbicide Funding from 2000–2011 (US$ millions)

Top Microbicide Funders for 2010 and 2011 (US$ millions)

Microbicide Funding from 2000–2011 (US$ millions)

Microbicide Expenditures from 2000–2011 (US$ millions)

Investment in Pre-Exposure Prophylaxis from 2005–2011 (US$ millions)

Annual Investments in Pre-Exposure Prophylaxis from 2005–2011 (US$ millions)

Funding for Vertical Transmission Prevention from R&D 2008–2011 (US$ millions)

Funding for Female Condom R&D in 2010 and 2011

Categories Used to Classify Preventive HIV Vaccine R&D Funding

Categories Used to Classify Microbicide R&D Funding